Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7120203 | 1.00 | POLB (0.33) | POLBTDP1LMNAALOX15BLM | |
| SCHEMBL476938 | 0.98 | — | — | |
| SCHEMBL476937 | 0.98 | — | — | |
| Chloromethane SCHEMBL1803778 | 0.93 | POLB (0.32) | POLBTDP1LMNAALOX15BLM | |
| Phosphoric Acid SCHEMBL27906100 | 0.89 | GRIN2D (0.32) | POLBLMNABLM | |
| Hydrochloric Acid SCHEMBL471896 | 0.86 | PAOX (0.37) | POLBLMNABLMPAOX | |
| Hydrochloric Acid SCHEMBL471897 | 0.86 | PAOX (0.37) | POLBLMNABLMPAOX | |
| SCHEMBL528542 | 0.85 | LMNA (0.39) | POLBTDP1LMNAALOX15BLM | |
| SCHEMBL528543 | 0.85 | LMNA (0.39) | POLBTDP1LMNAALOX15BLM | |
| SCHEMBL116656 | 0.84 | PAOX (0.38) | POLBTDP1LMNAALOX15BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12595396-B2 | Acid resistant filter media | ENTEGRIS, INC. (US) | 2026-04-07 | — | — | US | claimed |
| EP-3463631-B1 | COATED POROUS POLYMERIC MEMBRANES | ENTEGRIS INC (US) | 2024-09-04 | — | — | EP | claimed |
| CN-114230678-B | Photocrosslinked hydrogel embolism system for intravascular treatment and application method | 珠海通桥医疗科技有限公司 | 2023-09-01 | — | — | CN | claimed |
| US-11731085-B2 | Coated porous polymeric membranes | ENTEGRIS, INC. (US) | 2023-08-22 | — | — | US | claimed |
| CN-116265034-A | Multifunctional anticoagulation coating and plasma preparation method and application thereof | 中国科学院深圳先进技术研究院 | 2023-06-20 | — | — | CN | claimed |
| EP-4168165-A1 | COMPOSITE FILTER MEDIA | Entegris, Inc. (US) | 2023-04-26 | — | — | EP | claimed |
| EP-4168166-A1 | ACID RESISTANT FILTER MEDIA | Entegris, Inc. (US) | 2023-04-26 | — | — | EP | claimed |
| US-11618016-B2 | Grafted polysulfone membranes | ENTEGRIS, INC. (US) | 2023-04-04 | — | — | US | claimed |
| US-20220134287-A1 | COATED POROUS POLYMERIC MEMBRANES | MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT | 2022-05-05 | — | — | US | claimed |
| EP-3221035-B1 | GRAFTED ULTRA HIGH MOLECULAR WEIGHT POLYETHYLENE MICROPOROUS MEMBRANES | ENTEGRIS INC (US) | 2022-04-20 | — | — | EP | claimed |
| CN-109096450-A | Imitative mussel polymer of the hyperbranched cation of one kind and preparation method thereof | 四川汇利实业有限公司 | 2018-12-28 | — | — | CN | claimed |
| US-20180290109-A1 | GRAFTED ULTRA HIGH MOLECULAR WEIGHT POLYETHYLENE MICROPOROUS MEMBRANES | TRUIST BANK, AS NOTES COLLATERAL AGENT | 2018-10-11 | — | — | US | claimed |
| CN-108276303-A | A kind of synthetic method of sugar-containing polymer monomer N- (2-D- glucose amide bases ethyl) Methacrylamide | 中国科学院青岛生物能源与过程研究所 | 2018-07-13 | — | — | CN | claimed |
| US-20180185835-A1 | GRAFTED POLYSULFONE MEMBRANES | TRUIST BANK, AS NOTES COLLATERAL AGENT | 2018-07-05 | — | — | US | claimed |
| EP-3313556-A1 | GRAFTED POLYSULFONE MEMBRANES | Entegris, Inc. (US) | 2018-05-02 | — | — | EP | claimed |
| CN-107847873-A | GRAFTED POLYSULFONE MEMBRANES | 恩特格里斯公司 | 2018-03-27 | — | — | CN | claimed |
| WO-2017205722-A1 | COATED POROUS POLYMERIC MEMBRANES | ENTEGRIS, INC. (US) | 2017-11-30 | — | — | WO | claimed |
| EP-3221035-A1 | GRAFTED ULTRA HIGH MOLECULAR WEIGHT POLYETHYLENE MICROPOROUS MEMBRANES | Entegris, Inc. (US) | 2017-09-27 | — | — | EP | claimed |
| CN-107106997-A | Grafted ultra-high molecular weight polyethylene microporous membrane | 恩特格里斯公司 | 2017-08-29 | — | — | CN | claimed |
| US-20030152961-A1 | Polyfunctional support material for complex nucleic acid analysis | BENDZKO PETER (DE) | 2003-08-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12595396-B2 | Acid resistant filter media | SDC2, F7, SDC1 | POLB 1099/4885TDP1 2343/4885LMNA 432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.